首页> 美国卫生研究院文献>Cancer Science >Allelotype Analysis of Common Epithelial Ovarian Cancers with Special Reference to Comparison between Clear Cell Adenocarcinoma with Other Histological Types
【2h】

Allelotype Analysis of Common Epithelial Ovarian Cancers with Special Reference to Comparison between Clear Cell Adenocarcinoma with Other Histological Types

机译:常见上皮性卵巢癌的等位基因分析特别是将透明细胞腺癌与其他组织学类型进行比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Determination of the histological type of epithelial ovarian cancer is clinically important to predict patient prognosis. To estimate accurately the chromosomal regions that frequently show loss of heterozygosity (LOH) in each histological type, LOH at 55 loci on 38 chromosomal arms was examined by means of laser capture microdissection and PCR‐LOH analysis in 45 epithelial ovarian cancers composed of clear cell adenocarcinoma (CCA), serous adenocarcinoma (SEA), endometrioid adenocarcinoma (EMA) and mucinous adenocarcinoma (MUA). In addition, p53 (exons 5–8) gene mutations and the nuclear immunoreactivity of p53 proteins in these tumors were examined by PCR‐SSCP and immunohistochemistry. In CCA, LOH was detected primarily on 1p (69%) followed by 19p (45%) and 11q (43%). On the other hand, in SEA, LOH was detected in at least 50% of cases on 1p, 4p, 5q, 6p, 8p, 9q, 12q, 13q, 15q, 16p, 17p, 17q, 18p, 18q, 19p, 20p and Xp. The incidences of LOH on 5q, 12q, 13q and 17p were significantly lower in CCA than in SEA (P=0.019, 0.031, 0.0035 and 0.012). EMA showed a tendency for frequent LOH on 7p, whereas MUA showed significantly high occurrence of LOH at 17p13.1. The incidences of p53 mutation and p53 nuclear immunoreactivity also differed between CCA and SEA: 0% and 7% in the former and 64% and 45% in the latter (P=0.0006 and 0.039). These findings clarify that there are differences in LOH distribution patterns among different histological subtypes of epithelial ovarian cancer. In CCA, p53 tumor‐suppressor gene (TSG) is not involved in carcinogenesis and tumor‐suppressor genes located on 1p are considered to play an important role in tumor development.
机译:上皮性卵巢癌的组织学类型的确定对预测患者的预后具有重要的临床意义。为了准确估计每种组织学类型中经常显示杂合性(LOH)缺失的染色体区域,通过激光捕获显微切割和PCR-LOH分析,在45个由透明细胞组成的上皮性卵巢癌中检查了38个染色体臂上55个基因座的LOH腺癌(CCA),浆液性腺癌(SEA),子宫内膜样腺癌(EMA)和粘液性腺癌(MUA)。此外,通过PCR-SSCP和免疫组织化学检查了这些肿瘤中的p53(第5-8号外显子)基因突变和p53蛋白的核免疫反应性。在CCA中,主要在1p(69%)上检测到LOH,然后在19p(45%)和11q(43%)上检测到。另一方面,在SEA中,至少有50%的情况在1p,4p,5q,6p,8p,9q,12q,13q,15q,16p,17p,17q,18p,18q,19p,20p的情况下检测到LOH和Xp。 CCA中5q,12q,13q和17p的LOH发生率显着低于SEA(P = 0.019、0.031、0.0035和0.012)。 EMA在7p时表现出频繁发生LOH的趋势,而MUA在17p13.1时表现出明显较高的LOH发生率。在CCA和SEA之间,p53突变和p53核免疫反应的发生率也有所不同:前者为0%和7%,后者为64%和45%(P = 0.0006和0.039)。这些发现表明,上皮性卵巢癌的不同组织学亚型之间的LOH分布模式存在差异。在CCA中,p53肿瘤抑制基因(TSG)不参与致癌作用,位于1p的肿瘤抑制基因被认为在肿瘤发展中起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号